News Related to Valproate

Related coverage linked through entity extraction aliases.

Bipolar Depression Pipeline Expands With 10+ Therapies in Development Across 8+ Companies

Mar 12, 2026

The bipolar depression treatment pipeline includes over 10 therapies from 8+ companies, with recent Phase 3 trials initiated for azetukalner and multiple emerging drugs targeting novel pathways expected to launch by 2036.

Genetic Test Could Enable Safe Use of Epilepsy Drug Valproic Acid During Pregnancy

Feb 16, 2026

Researchers at Monash University have identified DNA sequence variations in mothers that modify the risk of birth defects from valproic acid, an anti-seizure medication, paving the way for a genetic test to identify who can safely take the drug during pregnancy.